Cargando…
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
Pancreatic cancer remains among the most lethal cancers worldwide, with poor early detection rates and poor survival rates. Patient-derived xenograft (PDX) models have increasingly been used in preclinical and clinical research of solid cancers to fulfil unmet need. Fresh tumour samples from human p...
Autores principales: | Roche, Sandra, O’Neill, Fiona, Murphy, Jean, Swan, Niall, Meiller, Justine, Conlon, Neil T., Geoghegan, Justin, Conlon, Kevin, McDermott, Ray, Rahman, Rozana, Toomey, Sinead, Straubinger, Ninfa L., Straubinger, Robert M., O’Connor, Robert, McVey, Gerard, Moriarty, Michael, Clynes, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037178/ https://www.ncbi.nlm.nih.gov/pubmed/32024004 http://dx.doi.org/10.3390/ijms21030962 |
Ejemplares similares
-
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors
por: O’Neill, Fiona, et al.
Publicado: (2023) -
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
por: Coleman, Orla, et al.
Publicado: (2018) -
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
por: McDermott, Martina SJ, et al.
Publicado: (2014) -
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
por: McDermott, Martina S. J., et al.
Publicado: (2023) -
Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
por: Straubinger, Julia, et al.
Publicado: (2013)